News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Vivo Capital IX, LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/12/2021 |
SC 13G
| Vivo Capital IX, LLC reports a 10.5% stake in IO Biotech, Inc. |
| 07/23/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 04/01/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 11/06/2020 |
SC 13G
| Vivo Capital IX, LLC reports a 4.4% stake in ESSA Pharma Inc. |
| 10/28/2020 |
SC 13G
| Vivo Capital IX, LLC reports a 16.2% stake in Tarsus Pharmaceuticals, Inc. |
| 07/29/2020 |
SC 13G
| Vivo Capital IX, LLC reports a 11.1% stake in ALX Oncology Holdings Inc. |
| 06/30/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 06/26/2020 |
SC 13G
| Vivo Capital IX, LLC reports a 5.8% stake in IVERIC bio, Inc. |
| 06/12/2020 |
SC 13G
| Vivo Capital IX, LLC reports a 6.6% stake in Mereo BioPharma Group plc |
| 06/11/2020 |
SC 13G
| Vivo Capital IX, LLC reports a 5.2% stake in Aduro Biotech, Inc. |
| 06/11/2020 |
SC 13G
| Vivo Capital IX, LLC reports a 4.3% stake in Larimar Therapeutics, Inc. |
| 02/03/2020 |
SC 13G
| Vivo Capital IX, LLC reports a 4.9% stake in Trillium Therapeutics, Inc. |
| 12/30/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
|
|